Redefining clinical trials: the age of personalized medicine.
paper
Cited
Public
Unavailable
- Authors
- Vaidyanathan, Gayathri
- Year
- 2012
- Journal
- Cell
- PMID
- 22424218
- DOI
- 10.1016/j.cell.2012.02.041
The triumph of personalized cancer therapeutics in recent years is prompting some oncologists to rethink clinical trial design; other researchers have different priorities for trial reform.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. | 2015 | 26142345 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Development and Applications of Organoids in Gynecological Diseases. | Yang J et al. | — | 2025 | → |
| Driving success in personalized medicine through AI-enabled computational modeling. | Chakravarty K et al. | — | 2021 | → |
| Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research. | Sun M et al. | — | 2020 | → |
| Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How. | Chen LS et al. | — | 2018 | → |
| Clonidine Increases the Likelihood That Abstinence Can Withstand Unstructured Time in Buprenorphine-maintained Outpatients. | Kowalczyk WJ et al. | — | 2017 | → |
| Determining the Optimal Neonatal Care for Preterm Infants in the Era of Personalized Medicine. | Lorch SA | — | 2017 | → |
| Strategies for Derisking Translational Processes for Biomedical Technologies. | Abou-El-Enein M et al. | — | 2017 | → |
| Theranostic barcoded nanoparticles for personalized cancer medicine. | Yaari Z et al. | — | 2016 | → |
| An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors. | Jonas O et al. | — | 2015 | → |
| Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. | Chen LS et al. | — | 2015 | → |
| Perspective: Does personalized medicine hold the future for medicine? | Agyeman AA et al. | — | 2015 | → |
| Metasignatures identify two major subtypes of breast cancer. | Duan Q et al. | — | 2013 | → |
| Network-based drug discovery by integrating systems biology and computational technologies. | Leung EL et al. | — | 2013 | → |
| Team Learning for Healthcare Quality Improvement. | Manukyan N et al. | — | 2013 | → |